FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

6 results

northera
(droxidopa)
Lundbeck Pharmaceuticals LLC
Usage: NORTHERA is indicated for treating orthostatic dizziness and lightheadedness in adults with symptomatic neurogenic orthostatic hypotension due to conditions like Parkinson's disease, multiple system atrophy, and autonomic neuropathy. Its effectiveness beyond two weeks is not established and should be assessed periodically.
onfi
(clobazam)
Lundbeck Pharmaceuticals LLC
Usage: ONFI® (clobazam) is indicated as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome (LGS) in patients aged 2 years and older.
sabril
(vigabatrin)
Lundbeck Pharmaceuticals LLC
Usage: SABRIL is indicated as adjunctive therapy for adults and pediatric patients (2 years and older) with refractory complex partial seizures and as monotherapy for pediatric patients (1 month to 2 years) with infantile spasms. Both uses consider the potential benefits versus the risk of vision loss.
sabril
(vigabatrin)
Lundbeck Pharmaceuticals LLC
Usage: SABRIL is indicated as adjunctive therapy for refractory complex partial seizures in patients aged 2 and older who have not responded to other treatments, and as monotherapy for infantile spasms in pediatric patients aged 1 month to 2 years, weighing the potential benefits against the risk of vision loss.
vyepti
(eptinezumab-jjmr)
Lundbeck Pharmaceuticals LLC
Usage: VYEPTI is indicated for the preventive treatment of migraines in adults.
xenazine
(tetrabenazine)
Lundbeck Pharmaceuticals LLC
Usage: XENAZINE is indicated for treating chorea associated with Huntington's disease.

Lundbeck Pharmaceuticals LLC drugs

northera

onfi

sabril

sabril

vyepti

xenazine